Virus News and Research

Latest Virus News and Research

Selecting SARS-CoV-2 inhibitors in human airway epithelial cells

In a recent article currently available on the bioRxiv* preprint server, researchers from Belgium and the U.S. demonstrated a robust replication model for the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) isolates in primary human epithelial cells at the air-liquid interface and appraised the antiviral effect of selected viral replication inhibitors.

28 Mar 2021

Covid-19 lockdown restrictions may have led to reduction in asthma exacerbations

Fewer patients with severe attacks were seen by their GP or admitted to hospital during the covid-19 pandemic, and fewer were admitted to hospital for pneumonia, influenza and chronic lung diseases, show findings from three papers published online in the journal Thorax.

27 Mar 2021

Researchers identify new drug candidates for treating patients with severe COVID-19

University of Maryland School of Medicine (UMSOM) researchers have identified the most toxic proteins made by SARS-COV-2--the virus that causes COVID-19 - and then used an FDA-approved cancer drug to blunt the viral protein's detrimental effects.

27 Mar 2021

Novel molecule could offer a new way to fight against SARS coronavirus 2

Scientists at the University of Bonn and the caesar research center have isolated a molecule that might open new avenues in the fight against SARS coronavirus 2. The active ingredient binds to the spike protein that the virus uses to dock to the cells it infects.

27 Mar 2021

New framework proposed to place restrictions on vulnerable communities at risk of COVID-19

As COVID-19 vaccines slowly roll out across the world, government officials in densely populated countries must still manage vulnerable communities at highest risk of an outbreak.

27 Mar 2021

Latino Californians are among hardest hit by COVID-19

The COVID-19 surge of summer through winter 2020‒2021 devastated all population groups. Yet when the death rates of Latinos are compared to non-Hispanic white (NHW) rates in every age group, there is a significant disparity between the two: Latino death rates are from two to seven times higher than NHW rates.

26 Mar 2021

Scientists share insights on operationalizing monoclonal antibody therapy for COVID-19

As evidence mounts supporting the use of monoclonal antibody treatment to reduce hospitalizations and deaths from COVID-19, UPMC and University of Pittsburgh School of Medicine physician-scientists are sharing the health system's experience administering the life-saving medication.

26 Mar 2021

Universal mask policy could reduce healthcare workers' risk of acquiring COVID-19

A study published in the Journal of Occupational and Environmental Medicine from researchers at Henry Ford Health System has found that Henry Ford's early implementation of a universal mask policy in the COVID-19 pandemic was associated with reducing the risk of healthcare workers at Henry Ford acquiring COVID-19.

26 Mar 2021

New project receives $9 million CIHR funding to track global threat of COVID-19 variants

A project spearheaded by a researcher at the University of Ottawa's Faculty of Medicine has been awarded $9 million in Canadian Institutes of Health Research (CIHR) funding to create a national network for better researching and responding to the global threat COVID-19 variants pose.

26 Mar 2021

A novel approach to oral vaccination against Covid-19

Scientists at the University of Würzburg together with a pharmaceutical company are working on a novel approach to oral vaccination against the coronavirus.

26 Mar 2021

POSTECH researchers produce artificial lung model using 3D printing

The warmer temperature and blooming flowers signal the arrival of spring. However, worries about respiratory diseases are also on the rise due to fine dust and viruses.

26 Mar 2021

Occupation not a reason for high COVID-19 rates among immigrants in Norway, finds study

A new study has found that the disproportionate rate of COVID-19 among immigrant groups in Norway may not be a result of occupational risks.

26 Mar 2021

New mathematical model identifies role of super-spreaders in SARS-CoV-2 variant emergence

Researchers have developed a new mathematical model which helps characterize factors responsible for the emergence of new SARS-CoV-2 variants and their predominance.

26 Mar 2021

How one state’s public health defunding led to vaccination chaos

Missourians have driven hours to find vaccines in rural counties — at least those with cars and the time. Tens of thousands of doses are waiting to be distributed, slowly being rolled out in a federal long-term care program.

26 Mar 2021

One dose of Pfizer vaccine generates strong immune response against COVID-19

A new study led by the Universities of Sheffield and Oxford with support from the UK Coronavirus Immunology Consortium (UK-CIC) has found that 99 per cent of people generate a robust immune response against Covid-19 after just one dose of the Pfizer vaccine.

26 Mar 2021

Can COVID-19 cause hearing loss, vertigo, and tinnitus?

Researchers at the University of Manchester, UK, aimed to systematically review the literature to provide evidence on SARS-CoV-2 and audio-vestibular symptoms. They found that COVID-19 has been tied to hearing loss, vertigo, and tinnitus.

26 Mar 2021

Newly identified pathway controls dangerous overreactions in the body's immune system

Scientists at Sinai Health say they have discovered a new pathway that controls dangerous overreactions in a body's immune system, including deadly forms of hyper-inflammation.

26 Mar 2021

Genomic sieve analysis can inform the development of SARS-Cov-2 vaccine

As concern has grown over COVID-19 variants and their implications for how well COVID-19 vaccines will protect against the virus, researchers have proposed a method to examine instances of SARS-COV-2 infections in people who have received a COVID-19 vaccine.

26 Mar 2021

Study: COVID-19 vaccines may remain effective against new influenza viruses

Influenza vaccines need to be evaluated every year to ensure they remain effective against new influenza viruses.

26 Mar 2021

Antibody used for COVID-19 therapy does not inhibit SARS-Cov-2 variants

Cell culture studies show that mutated viruses are less susceptible to inhibition by antibodies from recovered or vaccinated individuals.

26 Mar 2021

Virus News and Research

Latest Virus News and Research

Selecting SARS-CoV-2 inhibitors in human airway epithelial cells

Covid-19 lockdown restrictions may have led to reduction in asthma exacerbations

Researchers identify new drug candidates for treating patients with severe COVID-19

Novel molecule could offer a new way to fight against SARS coronavirus 2

New framework proposed to place restrictions on vulnerable communities at risk of COVID-19

Latino Californians are among hardest hit by COVID-19

Scientists share insights on operationalizing monoclonal antibody therapy for COVID-19

Universal mask policy could reduce healthcare workers' risk of acquiring COVID-19

New project receives $9 million CIHR funding to track global threat of COVID-19 variants

A novel approach to oral vaccination against Covid-19

POSTECH researchers produce artificial lung model using 3D printing

Occupation not a reason for high COVID-19 rates among immigrants in Norway, finds study

New mathematical model identifies role of super-spreaders in SARS-CoV-2 variant emergence

How one state’s public health defunding led to vaccination chaos

One dose of Pfizer vaccine generates strong immune response against COVID-19

Can COVID-19 cause hearing loss, vertigo, and tinnitus?

Newly identified pathway controls dangerous overreactions in the body's immune system

Genomic sieve analysis can inform the development of SARS-Cov-2 vaccine

Study: COVID-19 vaccines may remain effective against new influenza viruses

Antibody used for COVID-19 therapy does not inhibit SARS-Cov-2 variants

Industry Focus eBook - Infectious Diseases (3rd Edition) eBook

Voltammetry and machine learning for real-time neurotransmitter detection

How real-time off-gas analysis improves fermentation process control

Advancing Drug Safety Assessment With AI, Predictive Modeling, and Human-Relevant Data

Virus News and Research

Latest Virus News and Research

Industry Focus eBook - Infectious Diseases (3rd Edition) eBook

Voltammetry and machine learning for real-time neurotransmitter detection

How real-time off-gas analysis improves fermentation process control

Advancing Drug Safety Assessment With AI, Predictive Modeling, and Human-Relevant Data

Newsletters you may be interested in